![]() |
|
|
Vol. 301, Issue 1, 51-58, April 2002
1-Selective Agonist
(
)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol
[(
)-RO363] Differentially Interacts with Key Amino Acids
Responsible for
1-Selective Binding in Resting and
Active States
Laboratory of Pharmacology and Toxicology, Graduate School of
Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan (Y.S., R.F.,
T.N., H.K.); Toray Industries, Inc., Basic Research Laboratories,
Kanagawa, Japan (R.T.); Department of Molecular, Cell Pharmacology,
National Children's Medical Research Center, Tokyo, Japan (G.T.); and
Institute de Pharmacologie et de Toxicologie, Lausanne, Switzerland
(A.L.L., S.C.)
(
)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol
[(
)-RO363] is a highly selective
1-adrenergic
receptor (
1AR) agonist. To study the binding site of
1-selective agonist, chimeric
1/
2ARs and Ala-substituted
1ARs were constructed. Several key residues of
1AR [Leu110 and Thr117 in
transmembrane domain (TMD) 2], and Phe359 in TMD 7] were
found to be responsible for
1-selective binding of
(
)-RO363, as determined by competitive binding. Based on these results, we built a three-dimensional model of the binding domain for
(
)-RO363. The model indicated that TMD 2 and TMD 7 of
1AR form a binding pocket; the methoxyphenyl group of
N-substituent of (
)-RO363 seems to locate within the
cavity surrounded by Leu110, Thr117, and
Phe359. The amino acids Leu110 and
Phe359 interact with the phenyl ring of (
)-RO363, whereas
Thr117 forms hydrogen bond with the methoxy group of
(
)-RO363. To examine the interaction of these residues with
1AR in an active state, each of the amino acids was
changed to Ala in a constitutively active (CA)-
1AR
mutant. The degree of decrease in the affinity of CA-
1AR
for (
)-RO363 was essentially the same as that of wild-type
1AR when mutated at Leu110 and
Thr117. However, the affinity was decreased in
Ala-substituted mutant of Phe359 compared with that of
wild-type
1AR. These results indicated that
Leu110 and Thr117 are necessary for the initial
binding of (
)-RO363 with
1-selectivity, and
interaction of Phe359 with the N-substituent
of (
)-RO363 in an active state is stronger than in the resting state.
This article has been cited by other articles:
![]() |
D. M. Rosenbaum, V. Cherezov, M. A. Hanson, S. G. F. Rasmussen, F. S. Thian, T. S. Kobilka, H.-J. Choi, X.-J. Yao, W. I. Weis, R. C. Stevens, et al. GPCR Engineering Yields High-Resolution Structural Insights into 2-Adrenergic Receptor Function Science, November 23, 2007; 318(5854): 1266 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yin, S. Gavi, H.-y. Wang, and C. C. Malbon Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors Mol. Pharmacol., June 1, 2004; 65(6): 1323 - 1332. [Abstract] [Full Text] [PDF] |
||||